1-7 of 7
James J. Driscoll, II
Close
Sort by
Journal Articles

Toward AI-Assisted Clinical Assessment for Patients with Multiple Myeloma: Feature Selection for Large Language Models

Ehsan Malek, Gi-Ming Wang, Anant Madabhushi, Jennifer Cullen, Curtis Tatsuoka, James J. Driscoll, II
Journal: Blood
Blood (2023) 142 (Supplement 1): 2328.
https://doi.org/10.1182/blood-2023-172710
Published: 2023
Journal Articles

HDAC6 Inhibition Activates Proteasomes to Modulate the MHC Class I Immunopeptidome and Promote Antimyeloma Immunity

Priyanka S. Rana, James J. Ignatz-Hoover, Ehsan Malek, James J. Driscoll, II
Journal: Blood
Blood (2023) 142 (Supplement 1): 6586.
https://doi.org/10.1182/blood-2023-189262
Published: 2023
Journal Articles

Leveraging Artificial Intelligence to Uncover Hidden Biases in Survival Disparities of Patients with Multiple Myeloma

Ehsan Malek, Rishi Chopra, James J. Driscoll, II, Pingfu Fu
Journal: Blood
Blood (2023) 142 (Supplement 1): 7409.
https://doi.org/10.1182/blood-2023-172712
Published: 2023
Journal Articles

Utilizing a Machine Learning Approach to Define Racial Difference in Multi-Systemic Impact of Monoclonal Protein in Patient with Multiple Myeloma

Ehsan Malek, Gi-Ming Wang, Jennifer Cullen, Curtis Tatsuoka, Anant Madabhushi, James J. Driscoll, II
Journal: Blood
Blood (2023) 142 (Supplement 1): 7343.
https://doi.org/10.1182/blood-2023-172742
Published: 2023
Journal Articles

An Immunoproteasome Activator That Increases MHC Class I Antigen Presentation to Enhance Anti-Tumor Immunity

James J. Driscoll, II, Priyanka S. Rana, Ehsan Malek, James J. Ignatz-Hoover
Journal: Blood
Blood (2023) 142 (Supplement 1): 3642.
https://doi.org/10.1182/blood-2023-189541
Published: 2023
Journal Articles

PSMC2 Overexpression Enhances Proteasome Activity, Mitigates ER Stress, and Correleates with Reduced Overall Survival in Multiple Myeloma

James J. Ignatz-Hoover, E Ricky Chan, Jack D'Cruz, Pryianka Rana, Ehsan Malek, James J. Driscoll, II
Journal: Blood
Blood (2023) 142 (Supplement 1): 6617.
https://doi.org/10.1182/blood-2023-190462
Published: 2023
Journal Articles

Vactosertib, a Novel TGFb Type I Receptor Kinase Inhibitor, Improves T-Cell Fitness:a Single-Arm, Phase 1b Trial in Relapsed/Refractory Multiple Myeloma

Ehsan Malek, Priyanka S. Rana, Muthulekha Swamydas, Michael Daunov, Masaru Miyagi, Elena Murphy, James J. Ignatz-Hoover, Leland Metheny, Seong-Jin Kim, James J. Driscoll, II
Journal: Blood
Blood (2023) 142 (Supplement 1): 4749.
https://doi.org/10.1182/blood-2023-172711
Published: 2023